evorpacept

ALX follows Gilead in axing CD47 blood cancer trials as data disappoint
Fierce Biotech
Fri, 08/11/23 - 10:09 am
Gilead Sciences
ALX Oncology
blood cancer
clinical trials
anti-CD47
evorpacept
ALX and Sanofi partner to start Phase l/ll trial of RRMM combo therapy
Clinical Trials Arena
Wed, 04/26/23 - 10:26 am
ALX Oncology
Sanofi
clinical trials
evorpacept
Sarclisa
relapsed or refractory multiple myeloma